Basit öğe kaydını göster

dc.contributor.authorOZDAS, SB
dc.contributor.authorAFSAR, SELİM
dc.contributor.authorAkkan, Ahmet Gökhan
dc.contributor.authorOzyazgan, Sibel
dc.contributor.authorKUTLUATA, N
dc.date.accessioned2021-03-05T15:26:47Z
dc.date.available2021-03-05T15:26:47Z
dc.date.issued2005
dc.identifier.citationOzyazgan S., KUTLUATA N., AFSAR S., OZDAS S., Akkan A. G. , "Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats", PHARMACOLOGY, cilt.74, ss.119-126, 2005
dc.identifier.issn0031-7012
dc.identifier.otherav_bbf375a9-1166-4de2-ad47-f58530ca8b82
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/124941
dc.identifier.urihttps://doi.org/10.1159/000084277
dc.description.abstractWe investigated the vascular effects of glucagon-like peptide-1 (GLP-1) and Exendin-4 in type 2 diabetic rat aortae. Studies were performed in a normal control group (NC) (0.2 ml i. p. saline, n = 10), streptozotocin (STZ)/ nicotinamide diabetic control group ( DC) ( a single dose of 80 mg/kg STZ i. p. injection 15 min after administration of 230 mg/kg nicotinamide i. p.), GLP-1 (GLPC) control group ( 1 mu g/kg twice daily i. p. for 1 month, n = 10), Exendin-4 control group (EXC) ( 0.1 mu g/kg twice daily i. p. for 1 month, n = 10), GLP-1-treated diabetic group (GLPT) ( 1 mu g/kg twice daily i. p. for 1 month, n = 10), and Exendin-4-treated diabetic group (EXT) ( 0.1 mu g/kg twice daily i. p. for 1 month, n = 10). One month of GLP-1 and Exendin-4 treatment significantly decreased the blood glucose levels of diabetic rats ( 113 +/- 2 mg/dl, p < 0.001, and 117 +/- 1 mg/ dl, p < 0.001, respectively versus 181 +/- 9 mg/ dl in the DC group). Sensitivity (pD(2)) and maximum response (% Max. Relax) of acetylcholine-stimulated relaxations in the DC group (pD(2) : 6.73 +/- 0.12 and 55 +/- 6, respectively) were decreased compared with the nondiabetic NC group (pD(2) : 7.41 +/- 0.25, p < 0.05, and 87 +/- 4, p < 0.01). Treating diabetic rats with GLP-1, pD(2) values and with Exendin-4, Max. Relax % values of aortic strips to acetylcholine returned to near non-diabetic NC values (pD(2) : 7.47 +/- 0.15, p < 0.05, and 87 +/- 3, p < 0.01, respectively). Maximal contractile responses (E-max) to noradrenaline in aortic strips from the diabetic DC group (341 +/- 27 mg tension/mg wet weight) were significantly decreased compared with the non-diabetic NC ( 540 +/- 66 mg tension/mg wet weight, p < 0.001) and the GLPT group ( 490 +/- 25 mg tension/ mg wet weight, p < 0.05). There were no significant differences in pD(2) values of aortic strips to noradrenaline from all groups. E-max to KCl in aortic strips from the DC group ( 247 +/- 10 mg tension/ mg wet weight, p < 0.01) was significantly decreased compared with non-diabetic NC group ( 327 +/- 26 mg tension/ mg wet weight). Treating diabetic rats with GLP-1 (GLPT), E-max values of aortic strips to KCl returned to near non-diabetic NC values ( 271 +/- 12 mg tension/ mg wet weight). GLP-1 and ( partially) Exendin-4 treatment could improve the increased blood glucose level and normalize the altered vascular tone in type 2 diabetic rats. Copyright (C) 2005 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleEffect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats
dc.typeMakale
dc.relation.journalPHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume74
dc.identifier.issue3
dc.identifier.startpage119
dc.identifier.endpage126
dc.contributor.firstauthorID10955


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster